Healthcare -
Biotechnology - NASDAQ - US
$ 26.17
-18.6 %
$ 3.15 B
Market Cap
-9.09
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Avidity Biosciences, Inc.
| Revenue | 10.9 M |
| Cost Of Revenue | 2.78 M |
| Gross Profit | 8.12 M |
| Operating Expenses | 390 M |
| Operating Income | -379 M |
| Other Expenses | -56.6 M |
| Net Income | -322 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 10.9 | 9.6 | 9.2 | 9.3 | 6.8 | 2.3 | 0.4 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 2.8 | 2.1 | 1.4 | 0.6 | 37.6 | 14.5 | 8.4 |
| Gross Profit | 8.1 | 7.5 | 7.8 | 8.7 | (30.8) | (12.2) | (8.1) |
| OPERATING INCOME | |||||||
| Operating Expenses | 389.8 | 245.2 | 188.1 | 127.4 | 51.1 | 19.7 | 10.9 |
| Selling, General and Administrative Expenses | 86.2 | 54.2 | 37.7 | 26.2 | 13.5 | 5.1 | 2.4 |
| Research and Development Expenses | 303.6 | 191.0 | 150.4 | 101.2 | 37.6 | 14.5 | 8.4 |
| Operating Income | (378.9) | (235.6) | (178.9) | (118.1) | (44.3) | (17.3) | (10.5) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0 | 0 | 0 | 0.2 | 7.4 | 0.7 |
| Total Other Income | 56.6 | 23.4 | 4.9 | 42 K | 78 K | (7.4) | (0.7) |
| Pre-Tax Income | (322.3) | (212.2) | (174.0) | (118.0) | (44.4) | (24.7) | (11.2) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0 | (4.9) | (0.6) | (0.4) | 7.4 | 0.7 |
| Net Income | (322.3) | (212.2) | (169.1) | (117.4) | (44.0) | (32.1) | (11.9) |
| EPS | 2.89 | 2.91 | 3.24 | 2.83 | 2.03 | 0.86 | 0.58 |